BR112017000389A2 - sistema de expressão cistrônico duplo e processo de produção de proteínas - Google Patents

sistema de expressão cistrônico duplo e processo de produção de proteínas

Info

Publication number
BR112017000389A2
BR112017000389A2 BR112017000389A BR112017000389A BR112017000389A2 BR 112017000389 A2 BR112017000389 A2 BR 112017000389A2 BR 112017000389 A BR112017000389 A BR 112017000389A BR 112017000389 A BR112017000389 A BR 112017000389A BR 112017000389 A2 BR112017000389 A2 BR 112017000389A2
Authority
BR
Brazil
Prior art keywords
expression system
production process
protein production
cistronic expression
dual cistronic
Prior art date
Application number
BR112017000389A
Other languages
English (en)
Portuguese (pt)
Inventor
Varshney Brajesh
Salunkhe Shardul
SOORAPANENI Sudheerbabu
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of BR112017000389A2 publication Critical patent/BR112017000389A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/34—Cucurbitaceae, e.g. bitter melon, cucumber or watermelon 
    • A01H6/342—Citrullus lanatus [watermelon]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/27—Erwinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24029—Aureolysin (3.4.24.29)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112017000389A 2014-07-09 2015-07-09 sistema de expressão cistrônico duplo e processo de produção de proteínas BR112017000389A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2245MU2014 2014-07-09
PCT/IB2015/055189 WO2016005931A1 (en) 2014-07-09 2015-07-09 Dual cistronic bacterial expression system

Publications (1)

Publication Number Publication Date
BR112017000389A2 true BR112017000389A2 (pt) 2018-01-23

Family

ID=53773474

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017000389A BR112017000389A2 (pt) 2014-07-09 2015-07-09 sistema de expressão cistrônico duplo e processo de produção de proteínas

Country Status (20)

Country Link
US (2) US10329571B2 (enExample)
EP (1) EP3167065B1 (enExample)
JP (1) JP6748061B2 (enExample)
CN (1) CN106661588B (enExample)
AU (1) AU2015287296A1 (enExample)
BR (1) BR112017000389A2 (enExample)
CA (1) CA2954594A1 (enExample)
CY (1) CY1123303T1 (enExample)
DK (1) DK3167065T3 (enExample)
ES (1) ES2808906T3 (enExample)
HR (1) HRP20200996T1 (enExample)
HU (1) HUE050300T2 (enExample)
LT (1) LT3167065T (enExample)
MX (1) MX378585B (enExample)
PH (1) PH12017500047A1 (enExample)
PL (1) PL3167065T3 (enExample)
PT (1) PT3167065T (enExample)
RU (1) RU2732148C2 (enExample)
SI (1) SI3167065T1 (enExample)
WO (1) WO2016005931A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6435770B2 (ja) * 2014-01-21 2018-12-12 東ソー株式会社 シグナルペプチドをコードするポリヌクレオチドおよびそれを用いたタンパク質の製造方法
WO2017021819A1 (en) * 2015-07-31 2017-02-09 Dr. Reddy’S Laboratories Limited Process for preparation of protein or peptide
KR102607655B1 (ko) 2017-05-19 2023-11-28 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 리폴딩된 재조합 인간화 라니비주맙의 제조 방법
ES2965485T3 (es) * 2017-08-23 2024-04-15 Novartis Ag Sistema de expresión de proteínas con múltiples copias génicas
CN113631567B (zh) * 2018-07-06 2025-02-07 瓦克化学股份公司 在发酵方法中释放重组蛋白的细菌菌株
JP7762935B2 (ja) * 2019-01-31 2025-10-31 Ｓｐｉｂｅｒ株式会社 組換え細胞、発現構築物、及び組換えタンパク質の製造方法
KR20210148288A (ko) * 2019-04-02 2021-12-07 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 생체내 리폴딩된 항체 단편의 클로닝 및 발현
CN114774453B (zh) * 2022-03-14 2023-04-21 湖北大学 一种运动发酵单胞菌基因表达严谨调控系统的构建方法和应用
CN116334118A (zh) * 2023-02-23 2023-06-27 四川大学 一种原核体系中单启动子控制多个颗粒蛋白亚基组装同源等同体在胞内恒定比例表达并共自组装的方法
CN118995554B (zh) * 2024-09-09 2025-07-04 江南大学 一种大肠杆菌整合表达体系及其在酶高效表达中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
JP4309656B2 (ja) 2000-12-14 2009-08-05 ジェネンテック・インコーポレーテッド 原核生物で生成させた抗体とその用途
CA2454731C (en) 2001-08-27 2010-11-02 Genentech, Inc. A system for antibody expression and assembly
DK2046382T3 (en) * 2006-07-10 2016-12-12 Esbatech Alcon Biomed Res Unit scFv Antibodies which passes through the epithelial and / or endothelial layer
RU2413769C1 (ru) * 2009-12-24 2011-03-10 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET-32a, КОДИРУЮЩАЯ ГЕН ЛИГАНД-СВЯЗЫВАЮЩЕГО ДОМЕНА РЕЦЕПТОРА II ТИПА ТРАНСФОРМИРУЮЩЕГО ФАКТОРА РОСТА-β ЧЕЛОВЕКА (TβRII), ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ СЛИТНОГО БЕЛКА ТИОРЕДОКСИН/TβRII И СПОСОБ РЕНАТУРАЦИИ И ОЧИСТКИ ЦЕЛЕВОГО БЕЛКА TβRII
GB201002730D0 (en) * 2010-02-18 2010-04-07 Uni I Oslo Product
US8853380B2 (en) 2010-06-04 2014-10-07 Lupin Limited Modified SAK gene for the production of recombinant proteins
CA2904146C (en) * 2013-03-08 2023-03-21 Neuclone Biologics Pty Ltd A cell expression system
CA2911087A1 (en) * 2013-04-30 2014-11-06 Harish Shandilya Novel cloning, expression & purification method for the preparation of ranibizumab
TW201534726A (zh) * 2013-07-03 2015-09-16 Halozyme Inc 熱穩定ｐｈ２０玻尿酸酶變異體及其用途

Also Published As

Publication number Publication date
CY1123303T1 (el) 2021-12-31
EP3167065B1 (en) 2020-03-25
US20190309313A1 (en) 2019-10-10
CN106661588B (zh) 2020-11-06
ES2808906T3 (es) 2021-03-02
CA2954594A1 (en) 2016-01-14
AU2015287296A1 (en) 2017-02-02
WO2016005931A1 (en) 2016-01-14
HRP20200996T1 (hr) 2021-01-08
US11365418B2 (en) 2022-06-21
US20170159060A1 (en) 2017-06-08
US10329571B2 (en) 2019-06-25
DK3167065T3 (da) 2020-07-06
PL3167065T3 (pl) 2020-11-16
CN106661588A (zh) 2017-05-10
EP3167065A1 (en) 2017-05-17
SI3167065T1 (sl) 2020-09-30
HUE050300T2 (hu) 2020-11-30
JP2017520261A (ja) 2017-07-27
PT3167065T (pt) 2020-07-01
LT3167065T (lt) 2020-07-27
RU2732148C2 (ru) 2020-09-11
MX2017000332A (es) 2017-07-28
MX378585B (es) 2025-03-10
PH12017500047A1 (en) 2017-05-22
JP6748061B2 (ja) 2020-08-26

Similar Documents

Publication Publication Date Title
BR112017000389A2 (pt) sistema de expressão cistrônico duplo e processo de produção de proteínas
EA201790378A1 (ru) Заключенное в липосому аффинное лекарственное средство
HRP20181741T1 (hr) Postupci proizvodnje za kontrolu sadržaja c-terminalnog lizina, galaktoze i sijalinske kiseline u rekombiniranim proteinima
LT3559022T (lt) Baltymų pernešimas susilpinto virulentiškumo bakterijų dėka
EA201690314A1 (ru) Анти-garp-белок и его применения
MX375524B (es) Anticuerpos anti-axl.
PE20170665A1 (es) Anticuerpos anti-tau humanizados
BR112017023374A2 (pt) formulação de anticorpo anti-cgrp
CL2013001124A1 (es) Anticuerpo aislado o una proteína que comprende una porción de enlace de antígeno de un anticuerpo dirigido contra un polipéptido de cd40; composicion farmacéutica que comprende dicho anticuerpo; ácido nucleico que codifica el anticuerpo; vector de clonación; proceso de producción del anticuerpo.
MX384628B (es) Polipéptidos que tienen actividad de transgalactosilación.
IL261887A (en) Compositions containing tannic acids and uses thereof
EP3003062C0 (en) PRODUCTION OF DRIED VEGETABLE PROTEIN PRODUCTS WITH REDUCED ASTRINGENCY
BR112015004467A2 (pt) método para controlar a heterogeneidade de proteínas
GB2537077A (en) Methods for sequencing nucleic acids
SI3652491T1 (sl) Postopek liofiliziranja izdelka
BR112016025792A2 (pt) meios e processos para tratamento de cmv
GT201800102A (es) Polipéptidos que inhiben cd4ol
EP3329400A4 (en) DISAMBING OF SEARCH QUESTIONS
IL250646A0 (en) A process for conjugating a peptide or protein with a reagent containing a leaving group that includes a peg moiety
MD20150109A2 (ro) Construcţii proteice mitocondriale şi utilizările acestora
CL2018001718A1 (es) Sistema de depuración de dióxido de azufre y proceso para la producción de productos de potasio
MX2016013473A (es) Pared celular de levadura enriquecida en proteina de manano-oligosacarido.
IL249488B (en) Reduction of infections in healthcare settings using photocatalytic compositions
BR112018070139A2 (pt) expressão de proteínas em bactérias gram-negativas em que a razão entre o volume periplasmático e o volume citoplasmático é entre 0,5:1 e 10:1
EP3323832A4 (en) Antibody which specifically binds to human crth2

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements